Development of R₈ modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer

References

• Singh C, Qian JM, Yu JB, et al. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases. J Neurosurg. 2019;15:1–6.
   Web of Science ®Google Scholar
• Parchment RE, Doroshow JH. Theory and practice of clinical pharmacodynamics in oncology drug development. Semin Oncol. 2016;43:427–435.
   PubMed Web of Science ®Google Scholar
• Agustoni F, Suda K, Yu H, et al. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis. Cancer Treat Rev. 2019;72:15–27.
   PubMed Web of Science ®Google Scholar
• Naito Y, Yoshioka Y, Yamamoto Y, et al. How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol Life Sci. 2017;74:697–713.
   PubMed Web of Science ®Google Scholar
• Dearing KR, Sangal A, Weiss GJ. Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer. World J Clin Oncol. 2014;5:103–113.
   PubMedGoogle Scholar
• Wu H, Zhong Q, Zhong R, et al. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-alpha-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment. Int J Nanomed. 2016;11:6337–6352.
   PubMed Web of Science ®Google Scholar
• Dubey P, Gidwani B, Pandey R, et al. In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer. Artif Cells Nanomed Biotechnol. 2016;44:1491–1497.
   PubMed Web of Science ®Google Scholar
• M, Li Z J, Lin Z, et al. Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer. Am J Cancer Res. 2018;8:2402–2418.
   PubMed Web of Science ®Google Scholar
• Partridge AH, Carey LA. Unmet needs in clinical research in breast cancer: where do we need to go? Clin Cancer Res. 2017;23:2611–2616.
   PubMed Web of Science ®Google Scholar
• Shen J, Wang B, Zhang T, et al. Suppression of non-small cell lung cancer growth and metastasis by a novel small molecular activator of RECK. Cell Physiol Biochem. 2018;45:1807–1817.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhu R, Wang M, et al. Anti-metastatic and anti-angiogenic activities of core-shell SiO2@LDH loaded with etoposide in non-small cell lung cancer. Adv Sci. 2016;3:1600229.
   Web of Science ®Google Scholar
• Xiang T, Lin YX, Ma W, et al. Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nat Commun. 2018;9:5009.
   PubMed Web of Science ®Google Scholar
• Quiros-Gonzalez I, Tomaszewski MR, Aitken SJ, et al. Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry. Br J Cancer. 2018;118:1098–1106.
   PubMed Web of Science ®Google Scholar
• Yeung CL A, Co NN, Tsuruga T, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016;7:11150.
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng L, Xie HJ, et al. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2018;46:1154–1169.
   PubMed Web of Science ®Google Scholar
• Liu JY, Wu XY, Wu GN, et al. FOXQ1 promotes cancer metastasis by PI3K/AKT signaling regulation in colorectal carcinoma. Am J Transl Res. 2017;9:2207–2218.
   PubMed Web of Science ®Google Scholar
• Chida T, Miura Y, Cabral H, et al. Epirubicin-loaded polymeric micelles effectively treat axillary lymph nodes metastasis of breast cancer through selective accumulation and pH-triggered drug release. J Control Release. 2018;292:130–140.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhang T, Peng B, et al. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity. Int J Pharm. 2017;523:203–216.
   PubMed Web of Science ®Google Scholar
• Baek SH, Ko JH, Lee JH, et al. Ginkgolic acid inhibits invasion and migration and TGF-beta-induced EMT of lung cancer cells through PI3K/Akt/mTOR inactivation. J Cell Physiol. 2017;232:346–354.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ma Y, Jiang J, et al. Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells. Oncol Lett. 2014;7:1375–1380.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao S, Zhu J, et al. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway. Cancer Med. 2018;7:5704–5715.
   PubMed Web of Science ®Google Scholar
• Zheng C, Ma C, Bai E, et al. Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma . Int J Clin Exp Med. 2015;8:1658
   PubMed Web of Science ®Google Scholar
• Liu Y, Ran R, Chen J, et al. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials. 2014;35:4835–4847.
   PubMed Web of Science ®Google Scholar
• Kamei N, Yamaoka A, Fukuyama Y, et al. Noncovalent strategy with cell-penetrating peptides to facilitate the brain delivery of insulin through the blood-brain barrier. Biol Pharm Bullet. 2018;41:546–554.
   PubMed Web of Science ®Google Scholar
• Carita AC, Eloy JO, Chorilli M, et al. Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery. CMC. 2018;25:606–635.
   PubMed Web of Science ®Google Scholar
• Song XL, Liu S, Jiang Y, et al. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma. Eur J Pharm Sci. 2017;96:129–140.
   PubMed Web of Science ®Google Scholar
• Gu MM, Gao D, Yao PA, et al. P53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma. Cancer Sci. 2018;109:3783–3793.
   PubMed Web of Science ®Google Scholar
• Mei D, Zhao L, Chen B, et al. α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer. Drug Deliv. 2018;25:493–503.
   PubMed Web of Science ®Google Scholar
• Li XT, Ju RJ, Li XY. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Oncotarget. 2014;5:6497–6511.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Cheng L, Peng XM, et al. Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artif Cells Nanomed Biotechnol. 2018;46:616–628.
   PubMed Web of Science ®Google Scholar
• Zhao MH, Yuan L, Meng LY, et al. Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro. Exp Therap Med. 2017;14:5503–5508.
   PubMed Web of Science ®Google Scholar
• Song XL, Ju RJ, Xiao Y, et al. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. IJN. 2017;12:7433–7451.
   Web of Science ®Google Scholar
• Gu QY, Qiu X, Liu JJ, et al. Nanostructured layered terbium hydroxide containing NASIDs: in vitro physicochemical and biological evaluations. J Nanosci Nanotechnol. 2018;18:5320–5326.
   PubMed Web of Science ®Google Scholar
• Deshpande P, Jhaveri A, Pattni B, et al. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Drug Deliv. 2018;25:517–532.
   PubMed Web of Science ®Google Scholar
• Wan X, Kong Z, Chu K, et al. Co-expression analysis revealed PTCH1-3'UTR promoted cell migration and invasion by activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1. Oncotarget. 2018;9:4798–4813.
   PubMedGoogle Scholar
• Liu S, Zhang SM, Ju RJ, et al. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma. Eur J Pharm Sci. 2017;106:185–197.
   PubMed Web of Science ®Google Scholar
• Hu J, Chen LJ, Liu L, et al. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med. 2008;40:617–628.
   PubMed Web of Science ®Google Scholar
• Yuan R, Li S, Geng H, et al. Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis. Int Immunopharmacol. 2017;49:30–37.
   PubMed Web of Science ®Google Scholar
• Shen KH, Hung JH, Chang CW, et al. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Chem Biol Interact. 2017;268:129–135.
   PubMed Web of Science ®Google Scholar
• Li Y, Guo M, Lin Z, et al. Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis. Int J Nanomed. 2016;11:6693–6702.
   PubMed Web of Science ®Google Scholar
• Yu S, Sheu HM, Lee CH. Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis. Oncotarget. 2017;8:103509–103517.
   PubMedGoogle Scholar
• Sadat Shandiz SA, Shafiee Ardestani M, Shahbazzadeh D, et al. Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells. Artif Cells Nanomed Biotechnol. 2017;45:1–10.
   PubMed Web of Science ®Google Scholar